Steris (STE)
NYSEHealth CareMedical DevicesSnapshot 2026-07-08
$209.44-2.76%
Close 2026-07-08 · 1-day change
Reading STE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track STE free→NYSEHealth CareMedical DevicesSnapshot 2026-07-08
Reading STE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track STE free→Intact: The reason to own it still holds.
Steris aims to grow revenue by 7-8% in fiscal 2027. Free cash flow target is $850 million for 2027. The company has a moderate valuation with a PE of 21.17, cheaper than peers. Recent revenue growth from $1.39B to $1.59B in Q4 2026 shows positive momentum.
Steris missed Q4 earnings and cut guidance, raising concerns about sustaining revenue growth. EPS miss and guidance cut indicate possible margin pressure. CEO and CFO transitions may add uncertainty.
The price is about 5% above our fair value near $205, reflecting analyst expectations of about 8% revenue growth. Our view aligns with this but notes risks from recent earnings misses and guidance cuts.
Breaks if: EPS falls below $10.5 in FY27
Management aims to increase revenue by 7-8% for fiscal year 2027.
Newly stated in 2026-Q1. Revenue grew from $1.39B in 2026-Q1 to $1.59B in 2026-Q4, indicating a positive trajectory towards the 7-8% growth target for fiscal 2027.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“For fiscal 2027, the Company expects as reported revenue to increase 7-8%.”
Breaks if: Free cash flow falls below $800 million in FY27
Management targets achieving $850 million in free cash flow for fiscal year 2027.
Stated in 3 of last 3 quarters. Cash from operating activities increased from $298.2M in 2026-Q3 to $335.4M in 2026-Q4, showing progress towards the $850M free cash flow target for fiscal 2027.
“Free cash flow is expected to be approximately $850 million.”
“Free cash flow is expected to be approximately $850 million.”
“Free cash flow is now expected to be approximately $850 million.”
Breaks if: YoY revenue growth falls below 6% in FY27
Management aims to increase revenue by 7-8% for fiscal year 2027.
Newly stated in 2026-Q1. Revenue grew from $1.39B in 2026-Q1 to $1.59B in 2026-Q4, indicating a positive trajectory towards the 7-8% growth target for fiscal 2027.
“For fiscal 2027, the Company expects as reported revenue to increase 7-8%.”